Psychedelic medicine as a new direction in global health policy: why Ukraine needs professional lobbying and international advocacy
On May 6, 2026, the European Parliament held a discussion on the prospects of psychedelic-assisted therapy, a direction that is rapidly moving from the realm of narrow scientific discussions into the sphere of international health policy, regulatory law, and strategic medical diplomacy.
The participation of the Ukrainian side in this discussion has become not only a professional or scientific step, but also an advocacy one. In fact, we are talking about a much broader process - the formation of a new international architecture of solutions in the field of mental health after global crises, wars and humanitarian disasters.
And this is where the role of professional lobbying and advocacy begins.
A few years ago, the topic of MDMA or psilocybin was mainly in the realm of academic research. Today, the situation is changing dramatically.
Governments, parliaments, regulatory bodies, pharmaceutical companies, investment funds and international institutions are beginning to consider psychedelic-assisted therapy as a potential component of the future mental health system. The reason is simple: the world is facing a mental health crisis of unprecedented scale. Post-COVID effects, wars, professional burnout, depression, PTSD among military and civilian personnel, the increase in suicidal states and addictions are creating a colossal burden on health care systems even in the most developed countries. That is why international politics is gradually moving from denying this topic to finding mechanisms for its controlled regulation.
Why does Ukraine risk remaining just a “field for research” in this area without lobbying?
Today, a new market is forming in the world:
clinical trials;
biotechnology;
psychopharmacology;
educational programs;
medical protocols;
regulatory control systems;
international consortia in the field of mental health.
And if Ukraine does not begin to systematically work at the level of international advocacy now, the country risks remaining only a data collection area or a “recipient of foreign models.” Professional lobbying in the field of mental health today means:
participation in the formation of regulatory policy;
representation of Ukrainian interests in international institutions;
integration of Ukrainian clinics and research centers into global research programs;
creation of state control mechanisms;
patient protection;
access of Ukrainian doctors to international training programs;
attracting investment in medical innovations.
And most importantly, Ukraine's right to be not an object of foreign policy, but a subject of forming new rules.
Ten years ago, the issue of mental health was rarely part of international political negotiations. Today, the situation has changed. Mental health is gradually becoming part of: national security policy; veterans' policy; humanitarian diplomacy; post-war recovery programs; systems of economic stability of states; international security strategies. This is of particular importance for Ukraine. After the war, it is the mental state of the population that will determine:
economic productivity;
stability of state institutions;
the ability of veterans to return to civilian life;
demographic situation;
level of social tension;
risks of alcoholism, addictions and suicides.
In fact, it is about the long-term stability of the country. And that is why international negotiations on new approaches to treating PTSD or resistant depression already go far beyond medicine.
Ukraine has a unique experience - and this creates political weight!
The harsh truth is that Ukraine today has one of the world's largest bodies of experience dealing with war trauma. It is a terrifying experience, but at the same time it is a reality that shapes Ukraine's unique expertise.
World institutions understand that in the coming years, Ukraine will become one of the key countries in shaping practices for working with: PTSD; complex trauma; psychological consequences of war; professional burnout of doctors and military personnel; crisis psychiatry; long-term rehabilitation programs. This creates not only humanitarian but also political subjectivity for Ukraine.
Professional lobbying in the field of psychedelic medicine cannot be based on emotions, hype, or populism. Its foundation should be: evidence-based medicine; international law; ethical standards; GCP protocols; state control; a transparent regulatory system; protection of patients' rights; and intergovernmental cooperation.
Ukraine needs to: form expert platforms; create international coalitions; work with European parliamentary groups; integrate Ukrainian institutions into global research networks; prepare the legislative framework of the future; build a system of state monitoring and ethics. This is what real advocacy is - not promoting a "fashionable topic", but building a responsible state position in an area that in the next 10–15 years can radically change the world's approach to the treatment of mental disorders.
Ukraine has a chance to become not an observer, but a co-architect of a new system!
Today, the international community is just beginning to shape the rules of the future in the field of psychedelic-assisted therapy, and it is now being decided who will create protocols, who will shape regulatory approaches, who will become the center of clinical research, who will determine ethical standards, who will gain access to international investments and programs. For Ukraine, this is a window of opportunity. And if the state, expert community, scientific centers, and professional advocacy platforms begin to act systematically now, Ukraine has a chance to become not only a country that has survived the trauma of war, but also one of the global centers for the formation of a new model of mental health for the 21st century.